Seegene to Use Biosearch Fluorophores, Oligos in Molecular Dx Platforms | GenomeWeb

Biosearch Technologies said this week that it has signed a broad licensing and manufacturing agreement with Korea's Seegene covering fluorophore, quencher dye, and oligonucleotide technology.

Under the agreement, Novato, Calif.-based Biosearch has licensed to Seegene patents covering Biosearch's CAL Fluor and Quasar fluorophores and BHQ dark quencher dye.

In addition, Biosearch will manufacture research- and in vitro diagnostic-grade oligonucleotides for Seegene, the companies said.

Financial terms of the agreement were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV. 

Sponsored by

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.